Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/JAMP-MIRTAZAPINE

Authorized

STANDARD

JAMP-MIRTAZAPINE

Jamp Pharma Corporation🇨🇦 Health Canada

Approval Date: Sep 4, 2026
Approval ID: a849dbc6a7ddf2ce
Company: Jamp Pharma Corporation
Type: Standard

Approval Details

Approval Id: a849dbc6a7ddf2ce
Drug Approval Canada Name: JAMP-MIRTAZAPINE
Product Name: JAMP-MIRTAZAPINE
Status: Approved
Status Date: 2026-08-12
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: PRESCRIPTION
Atc Original: N06AX11 MIRTAZAPINE
Aig Number: 0143928003
Company Name: Jamp Pharma Corporation
Company Address: 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3
Company Detail Path: /organization/jamp-pharma-corporation

Company Information

Pharmaceutical Company Name: Jamp Pharma Corporation
Country Name: Canada
Province Name: British Columbia
City Name: chilliwack,british columbia,country_ca
Address: 8065 Aitken Rd

Active Ingredients

MIRTAZAPINE

45 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Sep 4, 2026

Approval ID

a849dbc6a7ddf2ce

Type

Standard

Back to Health Canada Approvals

JAMP-MIRTAZAPINE - Health Canada Drug Approval Details